FDA Inspection 828132 — Actelion Pharmaceuticals Ltd.

Actelion Pharmaceuticals Ltd. — FEI 3002995923

The FDA completed an inspection of Actelion Pharmaceuticals Ltd. on Apr 19, 2013 in Allschwil. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 19, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Allschwil (Switzerland)

Additional Details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.